Could cause temporary or reversible harm; serious harm is unlikely.
shortfill; reports of empty capsules.
| Brand name | DICYCLOMINE HYDROCHLORIDE |
| Generic name | DICYCLOMINE HYDROCHLORIDE |
| Active ingredient(s) | DICYCLOMINE HYDROCHLORIDE |
| Distributed by / for | Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520 |
| NDC | 59651-719-99 |
| Full product label | Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99 |
| Recalling firm | Aurobindo Pharma USA Inc |
| Distribution | US Nationwide. |
| Quantity | 6,408 bottles distributed to market |
| Recall initiated | 2026-07-23 |
| Report date | 2026-08-12 |
| Recall completed | — |
| Recall number | D-0733-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | East Windsor NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗